Novartis AG buy fenjal
Start price
11.12.16
/
50%
€66.30
Target price
14.03.17
€80.00
Performance (%)
10.44%
End price
14.03.17
€70.64
Summary
This prediction ended on 14.03.17 with a price of €70.64. The prediction had a final performance of 10.44%. fenjal has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novartis AG | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by fenjal for this prediction
In the thread Novartis AG diskutieren
fenjal stimmt dem Crowdsentiment von 'Buy' zu
fenjal stimmt am 11.12.2016 dem Buy-Crowdsentiment mit dem Kursziel 85.22€ zu.
(Vom Mitglied beendet)